Jabine van der Meijs

Non-Executive Director at Pharming Group

Ms. van der Meijs served as the Executive Vice President & CFO of the Royal Schiphol Group from 2017 until end of March 2021. Prior to this, Ms. van der Meijs worked for the Royal Dutch Shell Group (ENXTAM: RDSA) for 25 years in primarily financial leadership positions, but also in HR and strategy positions in The Netherlands, Scotland, England, Brunei, and Australia. In her most recent position at Shell, she was VP Finance Projects for Shell’s Projects and Technology business.

Ms. van der Meijs is currently a Member of the Supervisory Board of Kendrion N.V. (ENXTAM: KENDR) where she serves as Chairwoman of the Audit Committee. She is a Member of the Supervisory Board of Koole Terminals Holding B.V., where she serves as the Chair of the People & Remuneration Committee and she is a Member of the Board of Directors of Grundfos Holding A/S, a privately owned Danish Company. At Grundfos she serves as a member of the Audit committee, a member of the M&A committee and a member of the HR committee.

She also is a member of the Supervisory Board of CHDR (The Centre for Human Drug Research), an independent institute for early phase clinical drug research, where she is a member of the Audit Committee. Previously, Ms. van der Meijs served as a Non-Executive Director on various boards, including Aeroports de Paris (France) (ENXTPA: ADP) and Brisbane Airport Corporation (Australia).

Ms. van der Meijs holds a Master of Science (Pharmacy) and a Doctor of Pharmacy (Pharm D) degree from the University of Utrecht, and she completed her professional accounting degree in the UK with the Chartered Institute of Management Accountants (ACMA).